Skip to main content
Premium Trial:

Request an Annual Quote

MMRF, GNS Healthcare to Collaborate on CoMMpass Study

NEW YORK (GenomeWeb) – GNS Healthcare and the Multiple Myeloma Research Foundation announced today an agreement to use GNS' informatics solutions to explore genomic and clinical data from the Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile, or CoMMpass, study.

CoMMpass is an ongoing longitudinal study of 1,000 newly diagnosed patients with active multiple myeloma. Run by the MMRF, its objective is to map each of these patients’ genomic profiles to clinical outcomes to develop a more complete understanding of patient responses to treatments.

As part of this collaboration, GNS will use its reverse engineering and forward simulation technology inference engine to generate computer models based on data from the study's participants. The models could help researchers identify molecular pathways and targets that are involved in the disease's progression, novel potential therapeutic targets, and diagnostic biomarkers that could shed light on which treatments would work best for which patients, the partners said.

"Through creative, dynamic partnerships, we continually build new research models to accelerate development of the most promising treatments for patients with multiple myeloma," Walter Capone, president and CEO of the MMRF, said in a statement. "This collaboration with GNS to apply leading-edge computer models and analytics to uncover disease pathways in the diverse CoMMpass data set exemplifies this strategy."

Financial and other terms of the deal were not disclosed.


The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.